• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cost-effectiveness of a primary care-based Healthy Weight Clinic compared with usual care.基于初级保健的健康体重诊所与常规护理的成本效益比较。
Obesity (Silver Spring). 2024 Sep;32(9):1734-1744. doi: 10.1002/oby.24111.
2
Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults.替尔泊肽和司美格鲁肽对美国成年人的终生健康影响及成本效益
JAMA Health Forum. 2025 Mar 7;6(3):e245586. doi: 10.1001/jamahealthforum.2024.5586.
3
Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population.在服务不足人群中使用复方制剂预防心血管疾病的成本效益
JAMA Cardiol. 2025 Mar 1;10(3):224-233. doi: 10.1001/jamacardio.2024.4812.
4
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.6至11岁超重或肥胖儿童治疗中的饮食、身体活动及行为干预措施
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD012651. doi: 10.1002/14651858.CD012651.
5
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.在初级保健中使用药物治疗肥胖患者的临床效果和成本效益如何?系统评价。
Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
Balancing Efficiency and Equity in Population-Wide CKD Screening.在全人群慢性肾脏病筛查中平衡效率与公平性
JAMA Netw Open. 2025 Apr 1;8(4):e254740. doi: 10.1001/jamanetworkopen.2025.4740.
8
Strategies for enhancing the implementation of school-based policies or practices targeting risk factors for chronic disease.加强针对慢性病风险因素的校本政策或实践实施的策略。
Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD011677. doi: 10.1002/14651858.CD011677.pub2.
9
Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.改变卫生专业人员行为及护理组织方式的干预措施,以促进超重或肥胖儿童及成人减轻体重。
Cochrane Database Syst Rev. 2017 Nov 30;11(11):CD000984. doi: 10.1002/14651858.CD000984.pub3.
10
Consequences of weight cycling in patients with obesity and the potential impact of high protein diet: a health economic assessment from a US societal perspective.肥胖患者体重循环的后果及高蛋白饮食的潜在影响:从美国社会视角进行的健康经济评估
BMJ Open. 2025 Aug 18;15(8):e101058. doi: 10.1136/bmjopen-2025-101058.

本文引用的文献

1
Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.儿童和青少年肥胖评估与治疗临床实践指南
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2022-060640.
2
Trends in Obesity Prevalence Among Children and Adolescents Aged 2 to 19 Years in the US From 2011 to 2020.2011年至2020年美国2至19岁儿童及青少年肥胖患病率趋势
JAMA Pediatr. 2022 Oct 1;176(10):1037-1039. doi: 10.1001/jamapediatrics.2022.2052.
3
Methodological challenges surrounding QALY estimation for paediatric economic evaluation.儿科经济评估中围绕质量调整生命年(QALY)估计的方法学挑战。
Cost Eff Resour Alloc. 2022 Mar 3;20(1):10. doi: 10.1186/s12962-022-00345-4.
4
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.《2022 年健康经济评估报告标准》(CHEERS 2022)声明:健康经济评估报告的更新指南。
Value Health. 2022 Jan;25(1):3-9. doi: 10.1016/j.jval.2021.11.1351.
5
The Urgency of Expanding Access to Effective Treatment for Childhood Obesity.扩大儿童肥胖有效治疗可及性的紧迫性
Child Obes. 2021 Sep;17(S1):S3-S4. doi: 10.1089/chi.2021.29014.
6
Longitudinal Trends in Body Mass Index Before and During the COVID-19 Pandemic Among Persons Aged 2-19 Years - United States, 2018-2020.2018-2020 年美国 2-19 岁人群 COVID-19 大流行前后的体重指数纵向趋势。
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1278-1283. doi: 10.15585/mmwr.mm7037a3.
7
Comparative Effectiveness of Clinical and Community-Based Approaches to Healthy Weight.临床和社区为基础的健康体重管理方法的比较效果。
Pediatrics. 2021 Oct;148(4). doi: 10.1542/peds.2021-050405. Epub 2021 Sep 1.
8
Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.支付意愿以获得质量调整生命年:系统综述和荟萃回归分析。
Eur J Health Econ. 2022 Mar;23(2):277-299. doi: 10.1007/s10198-021-01364-3. Epub 2021 Aug 21.
9
Ethics of Implementing US Preventive Services Task Force Recommendations for Childhood Obesity.实施美国预防服务工作组关于儿童肥胖建议的伦理问题。
Pediatrics. 2021 Jul;148(1). doi: 10.1542/peds.2020-048009. Epub 2021 Jun 29.
10
Limiting Television to Reduce Childhood Obesity: Cost-Effectiveness of Five Population Strategies.限制儿童看电视时间以减少儿童肥胖:五种人群策略的成本效益分析。
Child Obes. 2021 Oct;17(7):442-448. doi: 10.1089/chi.2021.0016. Epub 2021 May 10.

基于初级保健的健康体重诊所与常规护理的成本效益比较。

Cost-effectiveness of a primary care-based Healthy Weight Clinic compared with usual care.

机构信息

Section of General Pediatrics, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.

Division of General Academic Pediatrics, Department of Pediatrics, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.

出版信息

Obesity (Silver Spring). 2024 Sep;32(9):1734-1744. doi: 10.1002/oby.24111.

DOI:10.1002/oby.24111
PMID:39192764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11361715/
Abstract

OBJECTIVE

The objective of this study was to project the cost-effectiveness of implementing the Healthy Weight Clinic (HWC), a primary care-based intervention for 6- to 12-year-old children with overweight or obesity, at federally qualified health centers (FQHCs) nationally.

METHODS

We estimated intervention costs from a health care sector and societal perspective and used BMI change estimates from the HWC trial. Our microsimulation of national HWC implementation among all FQHCs from 2023 to 2032 estimated cost per child and per quality-adjusted life year (QALY) gained and projected impact on obesity prevalence by race and ethnicity. Probabilistic sensitivity analyses assessed uncertainty around estimates.

RESULTS

National implementation is projected to reach 888,000 children over 10 years, with a mean intervention cost of $456 (95% uncertainty interval [UI]: $409-$506) per child to the health care sector and $211 (95% UI: $175-$251) to families (e.g., time participating). Assuming effect maintenance, national implementation could result in 2070 (95% UI: 859-3220) QALYs gained and save $14.6 million (95% UI: $5.6-$23.5 million) in health care costs over 10 years, yielding a net cost of $278,000 (95% CI: $177,000-$679,000) per QALY gained. We project greater reductions in obesity prevalence among Hispanic/Latino and Black versus White populations.

CONCLUSIONS

The HWC is relatively low-cost per child and projected to reduce obesity disparities if implemented nationally in FQHCs.

摘要

目的

本研究旨在预测在全国联邦合格健康中心(FQHC)实施基于初级保健的 6 至 12 岁超重或肥胖儿童的健康体重诊所(HWC)的成本效益。

方法

我们从医疗保健部门和社会角度估算了干预成本,并使用 HWC 试验的 BMI 变化估算值。我们对 2023 年至 2032 年期间全国所有 FQHC 实施 HWC 的微观模拟估计了每个儿童的成本和每个质量调整生命年(QALY)的收益,并预测了按种族和民族划分的肥胖患病率的影响。概率敏感性分析评估了估计的不确定性。

结果

预计全国实施将在 10 年内覆盖 888,000 名儿童,医疗保健部门对每个儿童的干预成本平均为 456 美元(95%置信区间[UI]:409-506 美元),家庭(例如,参与时间)为 211 美元(95% UI:175-251 美元)。假设效果维持,全国实施可能导致 2070 个(95% UI:859-3220)个 QALY 获得,并在 10 年内节省 1460 万美元(95% UI:5600 万美元至 23500 万美元)的医疗保健费用,净成本为每个 QALY 获得 278,000 美元(95% CI:177,000 美元至 679,000 美元)。我们预计,在全国 FQHC 实施 HWC 将降低西班牙裔/拉丁裔和黑人与白人之间肥胖患病率的差异。

结论

HWC 每个儿童的成本相对较低,如果在全国 FQHC 中实施,预计将减少肥胖的差异。